Takhzyro - NDC Database
3 records found
Page:
47783-645 Feb 03, 2023
Takhzyro 150 mg/ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
Takhzyro 150 mg/ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
47783-646 Feb 08, 2022
Takhzyro 300 mg/2ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
Takhzyro 300 mg/2ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.